Aft Forsyth & Sober’s Organon & Co OGN Stock Holding History

Aft Forsyth & Sober’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,300	Closed	-$39K	–	89
2021 Q2	$39K	Buy	+1,300	New	+$42.8K	0.01%	78

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Aft Forsyth & Sober's OGN Position: Q3 2021 in Review

Aft Forsyth & Sober sold out of Organon & Co (OGN) in Q3 2021, closing a stake of 1,300 shares — an estimated $39K sold.

Aft Forsyth & Sober first reported a position in OGN in Q2 2021 and held it in 1 quarter. The position peaked at $39K in Q2 2021. 927 funds tracked by Wall St. Rank hold OGN as of Q3 2021.

Aft Forsyth & Sober reported no remaining Organon & Co position as of Q3 2021 after selling out during the quarter.
Aft Forsyth & Sober sold 1,300 Organon & Co shares in Q3 2021, an estimated $39K.
Aft Forsyth & Sober first reported a position in Organon & Co in Q2 2021 and held it in 1 quarter.
Aft Forsyth & Sober's Organon & Co position peaked at $39K in Q2 2021.
927 funds tracked by Wall St. Rank held Organon & Co as of Q3 2021.

Based on Aft Forsyth & Sober's 13F filing for Q3 2021, filed 12 Nov 2021.